CD34 and systemic sclerosis: In conclusion, our data demonstrate that TC/CD34+ stromal cell changes in the skin of bleomycin-treated mice mimic very closely those observed in human SSc skin [31], which makes this experimental model a suitable tool to (i) further dissect the pathological mechanisms underlying TC damage and (ii) clarify the possible contribution of the TC loss to the development/progression of dermal fibrosis.